Filter Results


Study status

(for at least one location)



Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 20 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes on Insulin Therapy

    Scottsdale/Phoenix, AZ

  2. Fenofibrate for Prevention of DR Worsening

    Rochester, MN

  3. A Study to Evaluate the Impact of Nutrition Education and Access to Nutritious Foods on Diabetes Control

    Mankato, MN

  4. A Study to Evaluate the Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia

    Rochester, MN

  5. Stories for Change: Digital Storytelling for Diabetes Self-Management Among Somali Adults

    Rochester, MN

  6. Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes

    Rochester, MN

  7. A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2

    Rochester, MN

  8. A Study to Evaluate the Performance of an Advanced Algorithm with CGM in Adults, Adolescents, and Pediatrics

    Rochester, MN

  9. A Study to Evaluate the Effects of Niacin on FFA in UBO and T2DM in Insulin Resistant States

    Rochester, MN

  10. A Study to Evaluate the Effect of Improving Glycemic Control on Gastric Emptying in Type 1 and Type 2 Diabetes Mellitus

    Rochester, MN


Mayo Clinic Footer